Requests must originate independently from the applicant organization. The applicant remains responsible for the activity, its content and delivery. Submission does not guarantee funding.
Therapeutic areas
Novartis may consider funding requests in the following therapeutic areas. The activities eligible for support and funding availability may vary by country.
- Cardiovascular, Renal & Metabolism
- Immunology
- Neuroscience, including gene therapies
- Oncology, including cell and gene therapies
What your request must explain
| Activity scope and expected results | Describe the need, activities, deliverables, beneficiaries, location and timeline. Explain expected outcomes and how they will be assessed. Identify any component of a wider program. |
| Funding justification and detailed allocation | Explain why funding is needed and how the amount was determined. Provide the full activity budget and itemized costs, with quantities, unit costs and calculations where applicable. Identify the amount requested from Novartis for each item, other funding sources, shared-cost allocation and currency. Broad categories or lump sums without supporting detail are insufficient for assessment. |
| Governance and financial oversight | Identify accountability for delivery and funds. Explain how decisions, budgets and expenditure are approved, monitored and reported, including board or committee roles where applicable. Describe recipient selection and oversight for onward funding. |
Check consistency: Scope, deliverables, dates, currency and financial totals must agree across the application and supporting documents.
Submit and manage your request
Use GEMS to submit a new grant request or access an existing application. Follow any separate submission instructions specified in the applicable local guidance.
Review and funding conditions
Requests are assessed against applicable funding criteria, local requirements and available funding. Additional information may be requested.
Submission does not guarantee funding.